Compare CI & AME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CI | AME |
|---|---|---|
| Founded | 1792 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.8B | 52.7B |
| IPO Year | 2018 | 1998 |
| Metric | CI | AME |
|---|---|---|
| Price | $280.77 | $225.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $345.79 | $226.20 |
| AVG Volume (30 Days) | ★ 1.7M | 1.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.19% | 0.58% |
| EPS Growth | ★ 83.00 | 7.93 |
| EPS | ★ 22.18 | 6.40 |
| Revenue | ★ $274,900,000,000.00 | $7,401,116,000.00 |
| Revenue This Year | $5.75 | $8.94 |
| Revenue Next Year | $5.90 | $5.57 |
| P/E Ratio | ★ $12.86 | $36.72 |
| Revenue Growth | ★ 11.24 | 6.63 |
| 52 Week Low | $239.51 | $151.14 |
| 52 Week High | $350.00 | $242.05 |
| Indicator | CI | AME |
|---|---|---|
| Relative Strength Index (RSI) | 47.32 | 43.73 |
| Support Level | $280.76 | $176.64 |
| Resistance Level | $310.88 | $239.94 |
| Average True Range (ATR) | 5.94 | 5.10 |
| MACD | -0.79 | -1.28 |
| Stochastic Oscillator | 37.49 | 2.16 |
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.